Pharmerica (PMC) Misses Q3 EPS by 7c; Guides FY16 Below Views

November 9, 2016 8:09 AM EST

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Pharmerica (NYSE: PMC) reported Q3 EPS of $0.44, $0.07 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $512.6 million versus the consensus estimate of $530.01 million.

GUIDANCE:

Pharmerica sees FY2016 EPS of $1.84-$1.89, versus the consensus of $2.01. Pharmerica sees FY2016 revenue of $2.051-2.091 billion, versus the consensus of $2.13 billion.

For earnings history and earnings-related data on Pharmerica (PMC) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment